Monsanto Company (MON) Shares Bought by Piedmont Investment Advisors LLC

Piedmont Investment Advisors LLC raised its position in shares of Monsanto Company (NYSE:MON) by 0.2% in the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 93,761 shares of the basic materials company’s stock after buying an additional 227 shares during the period. Piedmont Investment Advisors LLC’s holdings in Monsanto were worth $11,098,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Puplava Financial Services Inc. boosted its position in shares of Monsanto by 0.4% during the second quarter. Puplava Financial Services Inc. now owns 2,119 shares of the basic materials company’s stock worth $251,000 after buying an additional 9 shares during the period. Savant Capital LLC boosted its position in shares of Monsanto by 0.4% during the first quarter. Savant Capital LLC now owns 3,082 shares of the basic materials company’s stock worth $349,000 after buying an additional 11 shares during the period. Guardian Life Insurance Co. of America boosted its position in shares of Monsanto by 0.7% during the first quarter. Guardian Life Insurance Co. of America now owns 1,689 shares of the basic materials company’s stock worth $191,000 after buying an additional 11 shares during the period. Enterprise Financial Services Corp boosted its position in shares of Monsanto by 1.2% during the second quarter. Enterprise Financial Services Corp now owns 1,384 shares of the basic materials company’s stock worth $164,000 after buying an additional 16 shares during the period. Finally, Forward Management LLC boosted its position in shares of Monsanto by 0.5% during the second quarter. Forward Management LLC now owns 3,201 shares of the basic materials company’s stock worth $379,000 after buying an additional 16 shares during the period. Institutional investors and hedge funds own 74.81% of the company’s stock.

In other Monsanto news, EVP Steven Mizell sold 11,526 shares of the company’s stock in a transaction dated Monday, October 9th. The shares were sold at an average price of $119.70, for a total value of $1,379,662.20. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, VP Duraiswami Narain sold 2,860 shares of the company’s stock in a transaction dated Monday, September 25th. The shares were sold at an average price of $120.00, for a total transaction of $343,200.00. The disclosure for this sale can be found here. Over the last three months, insiders sold 37,026 shares of company stock valued at $4,440,341. 0.79% of the stock is currently owned by corporate insiders.

Monsanto Company (MON) traded up 0.17% during mid-day trading on Thursday, reaching $120.00. The company’s stock had a trading volume of 579,087 shares. Monsanto Company has a 1-year low of $97.35 and a 1-year high of $120.50. The stock has a market capitalization of $52.74 billion, a P/E ratio of 23.58 and a beta of 1.07. The stock’s 50 day moving average price is $118.49 and its 200 day moving average price is $117.20.

Monsanto (NYSE:MON) last posted its quarterly earnings data on Wednesday, October 4th. The basic materials company reported $0.20 earnings per share for the quarter, beating analysts’ consensus estimates of ($0.41) by $0.61. The company had revenue of $2.69 billion during the quarter, compared to analysts’ expectations of $2.51 billion. Monsanto had a net margin of 15.44% and a return on equity of 42.40%. The firm’s revenue for the quarter was up 4.8% on a year-over-year basis. During the same period in the prior year, the company posted $0.07 EPS. Analysts expect that Monsanto Company will post $5.70 EPS for the current fiscal year.

The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 27th. Shareholders of record on Friday, October 6th will be given a $0.54 dividend. The ex-dividend date of this dividend is Thursday, October 5th. This represents a $2.16 dividend on an annualized basis and a yield of 1.80%. Monsanto’s payout ratio is currently 42.27%.

COPYRIGHT VIOLATION WARNING: This news story was posted by Sports Perspectives and is the sole property of of Sports Perspectives. If you are viewing this news story on another publication, it was illegally stolen and reposted in violation of U.S. & international trademark & copyright laws. The correct version of this news story can be read at https://sportsperspectives.com/2017/10/12/monsanto-company-mon-shares-bought-by-piedmont-investment-advisors-llc.html.

Several research analysts have recently commented on the company. UBS AG lowered Monsanto from a “positive” rating to a “neutral” rating in a research report on Tuesday, June 27th. BidaskClub lowered Monsanto from a “hold” rating to a “sell” rating in a report on Sunday, July 16th. Zacks Investment Research lowered Monsanto from a “buy” rating to a “hold” rating in a report on Wednesday, August 30th. Wells Fargo & Company lifted their target price on Monsanto from $107.50 to $118.00 and gave the company a “market perform” rating in a report on Tuesday. Finally, Piper Jaffray Companies set a $128.00 target price on Monsanto and gave the company a “buy” rating in a report on Friday, August 11th. Eleven investment analysts have rated the stock with a hold rating and four have issued a buy rating to the company. The stock has an average rating of “Hold” and an average target price of $124.61.

About Monsanto

Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.

Institutional Ownership by Quarter for Monsanto (NYSE:MON)

Receive News & Ratings for Monsanto Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Company and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply